 | • レポートコード：MRC2108A350 • 出版社/出版日：Mordor Intelligence / 2021年7月31日 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、分子分光法の世界市場規模が2020年6,350百万ドルから2026年9,545百万ドルまで、2021年から2026年の間に年平均6.8％成長すると予測しています。本調査資料では、世界の分子分光法市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（NMR分光法、ラマン分光法、紫外可視分光法、質量分光法、赤外分光法、その他）分析、用途別（製薬、食品・飲料試験、バイオテクノロジー・バイオ医薬品、環境試験、学術研究、その他）分析、地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・分子分光法の世界市場規模：種類別（NMR分光法、ラマン分光法、紫外可視分光法、質量分光法、赤外分光法、その他） ・分子分光法の世界市場規模：用途別（製薬、食品・飲料試験、バイオテクノロジー・バイオ医薬品、環境試験、学術研究、その他） ・分子分光法の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Agilent Technologies Inc.、Bruker Corporation、Danaher Corporation、Jeol Ltd、Horiba Ltd、Shimadzu Corporation、Thermo Fischer Scientific Inc.、Merck KGaA、PerkinElmer Inc.、VIAVI Solutions Inc.、Thorlabs Inc.、Bio-Rad Laboratories Inc.、Waters Corporation、Keit Ltd） ・市場機会/将来の見通し |
The molecular spectroscopy market was valued at approximately USD 6,350 million in 2020, and it is expected to reach USD 9,545 million by 2026, registering a CAGR of 6.8% during the forecast period, 2021-2026. The major factors driving the market include the rapid adoption in the pharmaceutical industry, penetration of MS technology in various verticals, and increased emphasis on the discovery of newer molecules by pharmaceuticals.
The growing COVID-19 pandemic has also had a positive impact on the market as scientists are increasing the applications of Raman spectroscopy for COVID-19 testing. For instance, a Northern Arizona University (NAU) research team was found developing a new test technology for SARS-CoV-2 using single-molecule surface-enhanced Raman spectroscopy (SM-SERS). The project was named “Development of a New Test for SARS-CoV-2 Using Single-Molecule Surface-Enhanced Raman spectroscopy” and was awarded a USD 200,000 grant from the National Science Foundation’s Rapid Response Research (RAPID) funding program. Therefore, with the increase in research and development activities by pharmaceuticals, related to drug discovery, the demand for molecular spectroscopy is consistently expected to grow over the forecast period.
Molecular spectroscopy is being used in the field of R&D of pharmaceuticals and other biotechnology products, and one of the molecular spectroscopy types used in R&D is near-infrared spectroscopy (NIR). In recent years, NIR spectroscopy has also gained a wide appreciation within the pharmaceutical industry due to its major advantages over other analytical techniques that include an easy sample preparation and the expectation of chemical and physical sample parameters from one single spectrum. Therefore, the rising affinity toward this technology has been widely noted, which may drive the growth of the market.
Furthermore, molecular spectroscopy is also found to be widely adopted across different application sectors, including pharmaceuticals and many others. Raman spectroscopy has proven to be a strong analytical technique for drug discovery and pharmaceutical development. It is being used to study the structural activity relationships and optimize the reaction conditions and other parameters, such as polymorph and formulation screening, which lead to the scaling up required for the transfer of drug compounds from discovery to development. Hence, the studied market is expected to grow rapidly during the forecast period.
Key Market Trends
The NMR Spectroscopy Segment is Expected to Observe Good Growth Over the Forecast Period
Nuclear magnetic resonance (NMR) spectroscopy is an analytical chemistry technique used in quality control and research for determining the content and purity of a sample as well as its molecular structure. The advantages of NMR spectroscopy are that it requires less sample preparation and a non-destructive method, and thus, retains the molecules being examined.
With the rise in COVID-19 disease, there is an increasing demand for research and development activities by pharmaceutical companies that have stimulated the demand for drug discovery and development.
In the course of recent years, NMR spectroscopy has become the leading technique for determining the structure of organic compounds and it has wide usage in application areas, like pharmaceuticals, biotechnology and biopharmaceuticals, food and beverage testing, environmental testing, and research institutes. In addition, NMR spectroscopy is also increasingly being used in biochemical and biological application areas, including hit and lead discovery, metabolite profiling, in-vivo spectroscopy (MRS), and imaging (MRI).
Many new developments have been observed in NMR spectroscopy, which are driving the much-needed improvement in sensitivity and versatility that is expanding the number of applications. In October 2020, Bruker Corporation announced the European launch of Fourier 80 system, which is a nuclear magnetic resonance (FT-NMR) benchtop spectrometer. There are also many new developments that are expected to lead to significant market growth during the forecast period.
North America is Expected to Witness High Growth Over the Forecast Period
North America is found driving the market due to increased usage of molecular spectroscopy in the pharmaceutical sector, increased funding for environmental testing, rising concerns about food safety, and favorable government initiatives and policies.
Since the COVID-19 virus outbreak, due to the lockdown, the production and supply chain of spectroscopic instruments have been restricted. Hence, the studied market is expected to be impacted during the pandemic. According to the article published on the National Institute of Health 2020, spectroscopy is being widely used for detecting and monitoring COVID-19. However, the local players have experienced an increase in the research and development activities related to drug discovery against COVID-19 by various pharmaceutical companies.
For instance, according to the Pharmaceutical Research and Manufacturers Association (PhRMA), the United States is the largest biopharmaceuticals market, accounting for one-third of the global market and a world leader in biopharmaceutical R&D. Also, the United States has the world’s most supportive domestic environment for the research, development, and commercialization of pharmaceuticals with minimal market barriers. Thus, the use of the spectroscopic technique in drug discovery and development in the United States is expected to rise over the years.
In Canada, there is also the presence of many pharma companies that continue to play a key role in propelling the growth of the market.
In January 2021, numares AG and Bruker Corporation announced a collaboration agreement to develop novel diagnostics tests utilizing NMR spectroscopy.
In November 2018, Agilent Technologies Inc. also launched the Cary 3500 UV-Visible Spectrophotometer, designed for research communities in life sciences, pharma, and biopharma, that helps by simplifying the analyses, optimizing laboratory productivity, and finally leading to the development of new therapeutics. Thus, the increasing R&D activities in drug discovery and development in pharmaceutical companies in the country, along with the new product launches by major players in the United States, are expected to drive the molecular spectroscopy market in the country during the forecast period.
Competitive Landscape
The market for molecular spectroscopy is moderately competitive. With the growing applications of molecular spectroscopy, new players are looking forward to entering the market. In terms of the market share, few companies, such as Thermo Fisher Scientific Inc., Agilent, Bruker, and Danaher, have better records from the past few years. The players are also involved in activities like mergers, acquisitions, joint ventures, partnerships, and collaborations. These activities help in increasing the influence of the players in the molecular spectroscopy market, eventually driving the market growth.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Adoption in the Pharmaceutical Industry
4.2.2 Penetration of MS Technology in Various Verticals
4.2.3 Increased Emphasis for Discovery of Newer Molecules by Pharmaceuticals
4.3 Market Restraints
4.3.1 High Cost of Maintenance and Installation Charges
4.3.2 Need of Technically Skilled Personnel
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type of Spectroscopy
5.1.1 NMR Spectroscopy
5.1.2 Raman Spectroscopy
5.1.3 UV-visible Spectroscopy
5.1.4 Mass Spectroscopy
5.1.5 Infrared Spectroscopy
5.1.6 Near-infrared Spectroscopy
5.1.7 Other Types of Spectroscopy
5.2 By Application
5.2.1 Pharmaceutical Applications
5.2.2 Food and Beverage Testing
5.2.3 Biotechnology and Biopharmaceutical Applications
5.2.4 Environmental Testing
5.2.5 Academic Research
5.2.6 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Bruker Corporation
6.1.3 Danaher Corporation
6.1.4 Jeol Ltd
6.1.5 Horiba Ltd
6.1.6 Shimadzu Corporation
6.1.7 Thermo Fischer Scientific Inc.
6.1.8 Merck KGaA
6.1.9 PerkinElmer Inc.
6.1.10 VIAVI Solutions Inc.
6.1.11 Thorlabs Inc.
6.1.12 Bio-Rad Laboratories Inc.
6.1.13 Waters Corporation
6.1.14 Keit Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS